Medicare Enrolled
Dr. James Vestal, MD
Urology Physician · Arlington, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vestal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vestal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vestal
Dr. James Vestal is an urology physician in Arlington, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Vestal performed 8,759 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Vestal received a total of $314,401 from 58 pharmaceutical and/or device companies across 771 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vestal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 11% volume in TX
$314,401 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗8,759
Medicare services
Top 11% in TX for urology physician
Not available
Unique patients (not deduplicated)
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 2,220 | $18 | $53 |
| BCG treatment for bladder cancer | 1,890 | $2 | $9 |
| Leuprolide injectable, camcevi, 1 mg | 1,344 | $64 | $195 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
706 | $87 | $278 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
301 | $48 | $122 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
274 | $6 | $12 |
| PSA test (prostate cancer screening) | 208 | $18 | $41 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
201 | $3 | $8 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
168 | $2 | $5 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
154 | $6 | $14 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
146 | $47 | $122 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
116 | $175 | $532 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
115 | $8 | $23 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 108 | $129 | $374 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
105 | $25 | $57 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
88 | $10 | $23 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
82 | $68 | $201 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
70 | $65 | $201 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
67 | $8 | $19 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
62 | $11 | $32 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
60 | $129 | $373 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
50 | $26 | $78 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
50 | $37 | $120 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
46 | $0 | $1 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $130 | $361 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
22 | $95 | $982 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
15 | $58 | $176 |
| Bladder tumor removal via endoscope This procedure involves using an endoscope to destroy or remove a large growth from the bladder. |
13 | $286 | $845 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
13 | $176 | $516 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
13 | $100 | $299 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
13 | $18 | $53 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $135 | $391 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.3% high complexity
28.8% medium
71.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$314,401
Total received (2018-2024)
Avg $44,914/year across 7 years
Top 2% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
771
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$37,384
2023
$25,871
2022
$44,856
2021
$27,895
2020
$16,021
2019
$60,402
2018
$101,974
Payments by company (2024)
Janssen Biotech, Inc.
$18,938
Bayer Healthcare Pharmaceuticals Inc.
$11,566
AstraZeneca Pharmaceuticals LP
$3,018
Ferring Pharmaceuticals Inc.
$1,868
Dendreon Pharmaceuticals LLC
$553
UROGEN PHARMA, INC.
$450
Johnson & Johnson Health Care Systems Inc.
$227
Sumitomo Pharma America, Inc.
$192
Astellas Pharma US Inc
$104
Olympus America Inc.
$84
ABBVIE INC.
$75
Verity Pharmaceuticals Inc.
$71
Axonics, Inc.
$60
Tolmar, Inc.
$50
Merck Sharp & Dohme LLC
$46
Blue Earth Diagnostics Limited
$24
ACCORD HEALTHCARE, INC.
$17
Cook Medical LLC
$17
PROGENICS PHARMACEUTICALS, INC.
$16
Mission Pharmacal Company
$7
Top 3 companies account for 89.7% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$150,873
Janssen Scientific Affairs, LLC
$60,442
GENZYME CORPORATION
$44,486
Bayer Healthcare Pharmaceuticals Inc.
$11,976
Bayer HealthCare Pharmaceuticals Inc.
$11,776
Blue Earth Diagnostics Limited
$8,227
AstraZeneca Pharmaceuticals LP
$5,697
Verity Pharmaceuticals Inc.
$3,702
Dendreon Pharmaceuticals LLC
$3,549
Clovis Oncology, Inc.
$3,279
Ferring Pharmaceuticals Inc.
$2,128
Boston Scientific Corporation
$1,063
HealthTronics Mobile Solutions, LLC
$959
UROGEN PHARMA, INC.
$746
Astellas Pharma US Inc
$612
TOLMAR Pharmaceuticals, Inc.
$548
Sun Pharmaceutical Industries Inc.
$323
Sumitomo Pharma America, Inc.
$299
Palette Life Sciences, Inc.
$293
Olympus America Inc.
$260
AbbVie Inc.
$252
Myovant Sciences Inc.
$237
Johnson & Johnson Health Care Systems Inc.
$227
Merck Sharp & Dohme LLC
$170
Endocare, Inc.
$162
Merck Sharp & Dohme Corporation
$152
NeoTract Inc.
$152
Axonics, Inc.
$142
Agiliti Surgical, Inc.
$131
Amgen Inc.
$131
Novartis Pharmaceuticals Corporation
$124
BOSTON SCIENTIFIC CORPORATION
$123
Janssen Products, LP
$100
PROCEPT BioRobotics Corporation
$94
AbbVie, Inc.
$91
ABBVIE INC.
$90
Coloplast Corp
$83
Myriad Genetic Laboratories, Inc.
$75
Ambu Inc.
$68
Progenics Pharmaceuticals, Inc.
$62
Aesculap, Inc.
$57
Tolmar, Inc.
$50
SANOFI-AVENTIS U.S. LLC
$48
Innovation Technologies Inc
$46
UroGen Pharma, Inc.
$42
Mission Pharmacal Company
$36
Baxter Healthcare
$34
ACCORD HEALTHCARE, INC.
$31
Covidien LP
$24
Retrophin, Inc.
$23
Cook Medical LLC
$17
MENARINI SILICON BIOSYSTEMS, INC.
$16
PROGENICS PHARMACEUTICALS, INC.
$16
Allergan Inc.
$13
UroViu Corporation
$13
Endo Pharmaceuticals Inc.
$12
PFIZER INC.
$12
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 81.4% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AquaBeam Robotic System · Axonics · Axumin · BOTOX · BRACANALYSIS CDX · Bulkamid · CAIMAN VESSEL SEALERS · CAMCEVI · Cellsearch · DARZALEX · ELIGARD · ERLEADA · Endocare Cryocare System · Erleada · FIRMAGON · FLOSEAL · GEMTESA · GENERAL BPH · GENERAL FEMALE SUI · GENERAL BPH · IMFINZI · IRRISEPT · Isiris aStent Removal Device · JELMYTO · JEVTANA · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · Mobile Cryoblation Services · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · POSLUMA · PROLARIS · PROSTATE CANCER - DISEASE · PROVENGE · PYLARIFY · Prolaris · RESONANCE · RUBRACA · Rubraca · SPACEOAR · STELARA · SUTENT · TAXOTERE · TISSEEL · Trelstar · Truqap · URIBEL TABS · Uribel · Uro-G Flexible Cystoscope · UroLift · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA · iDrive · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
144
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
USMD HOSPITAL AT ARLINGTON L P
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vestal is a clinical cardiology specialist, with above-average Medicare volume (top 11% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vestal experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Vestal performed 2,220 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Vestal receive payments from pharmaceutical companies?
Yes. Dr. Vestal received a total of $314,401 from 58 companies across 771 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vestal's costs compare to other urology physicians in Arlington?
Dr. Vestal's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vestal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Arlington
Browse urology physicians in Arlington ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Janssen Scientific Affairs, LLC Payments to Doctors
See all physicians who received payments from Janssen Scientific Affairs, LLC.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology